These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


60 related items for PubMed ID: 23311429

  • 1. Dynamics of stochastic mutation to immunodominance.
    Wu Y, Zhao X, Zhang M.
    Math Biosci Eng; 2012 Oct; 9(4):937-52. PubMed ID: 23311429
    [Abstract] [Full Text] [Related]

  • 2. Antigenic oscillations and shifting immunodominance in HIV-1 infections.
    Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Köppe B, Sigmund K, Bangham CR.
    Nature; 1995 Jun 15; 375(6532):606-11. PubMed ID: 7791879
    [Abstract] [Full Text] [Related]

  • 3. The coalescence of intrahost HIV lineages under symmetric CTL attack.
    Leviyang S.
    Bull Math Biol; 2012 Aug 15; 74(8):1818-56. PubMed ID: 22644341
    [Abstract] [Full Text] [Related]

  • 4. Immune responses against multiple epitopes.
    Nowak MA, May RM, Sigmund K.
    J Theor Biol; 1995 Aug 07; 175(3):325-53. PubMed ID: 7475080
    [Abstract] [Full Text] [Related]

  • 5. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.
    Wolpert EZ, Grufman P, Sandberg JK, Tegnesjö A, Kärre K.
    J Immunol; 1998 Nov 01; 161(9):4499-505. PubMed ID: 9794374
    [Abstract] [Full Text] [Related]

  • 6. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
    Barouch DH, Powers J, Truitt DM, Kishko MG, Arthur JC, Peyerl FW, Kuroda MJ, Gorgone DA, Lifton MA, Lord CI, Hirsch VM, Montefiori DC, Carville A, Mansfield KG, Kunstman KJ, Wolinsky SM, Letvin NL.
    Nat Immunol; 2005 Mar 01; 6(3):247-52. PubMed ID: 15685174
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J, Ahlén G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljeström P, Weiland O, Milich DR, Bartenschlager R, Sällberg M.
    Gut; 2006 Feb 01; 55(2):266-74. PubMed ID: 16105887
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS.
    Kawashima Y, Satoh M, Oka S, Shirasaka T, Takiguchi M.
    Biochem Biophys Res Commun; 2008 Feb 15; 366(3):612-6. PubMed ID: 18035044
    [Abstract] [Full Text] [Related]

  • 11. Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery.
    Sandberg JK, Grufman P, Wolpert EZ, Franksson L, Chambers BJ, Kärre K.
    J Immunol; 1998 Apr 01; 160(7):3163-9. PubMed ID: 9531271
    [Abstract] [Full Text] [Related]

  • 12. Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.
    Bodewes R, Geelhoed-Mieras MM, Nieuwkoop NJ, Hanson JA, David CS, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.
    Virus Res; 2011 Jan 01; 155(1):123-30. PubMed ID: 20863862
    [Abstract] [Full Text] [Related]

  • 13. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.
    Tine JA, Firat H, Payne A, Russo G, Davis SW, Tartaglia J, Lemonnier FA, Demoyen PL, Moingeon P.
    Vaccine; 2005 Jan 11; 23(8):1085-91. PubMed ID: 15620483
    [Abstract] [Full Text] [Related]

  • 14. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
    Pion S, Fontaine P, Desaulniers M, Jutras J, Filep JG, Perreault C.
    Eur J Immunol; 1997 Feb 11; 27(2):421-30. PubMed ID: 9045913
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing Tumors.
    Bioley G, Guillaume P, Luescher I, Bhardwaj N, Mears G, Old L, Valmori D, Ayyoub M.
    J Immunother; 2009 Feb 11; 32(2):161-8. PubMed ID: 19238015
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
    Boon AC, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.
    J Virol; 2006 Jun 11; 80(12):6024-32. PubMed ID: 16731941
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.